We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

New Jersey

  • September 8, 2008

    HSBC Seeks Sanctions In Overtime Case

    HSBC Mortgage Corp. moved Friday to sanction the plaintiffs' lawyer in an overtime, meal and rest period compensation and unlawful deductions suit, alleging that the lawyer directed a class representative to destroy evidence.

  • September 8, 2008

    Barr Fires Back At Celgene In Thalomid Patent Case

    In the latest salvo over generic versions of the cancer drug Thalomid, generic-drug maker Barr Laboratories Inc. said on Thursday that Celgene Corp.'s patent claims are unenforceable because the inventor withheld material information as the application wended its way through the U.S. Patent and Trademark Office.

  • September 5, 2008

    $250M Boscov's DIP Financing Approved

    Bankrupt department store chain Boscov's Inc. has received final approval of a $250 million debtor-in-possession loan that the company says will allow it to continue its operations with an uninterrupted "merchandise flow" going into the holiday sales season.

  • September 4, 2008

    Judge Denies GSK Plea To Drop Paxil Suicide Case

    A federal judge has rejected drugmaker GlaxoSmithKline PLC's contention that federal law preempts a failure-to-warn product liability suit over Paxil, in a case involving a 16-year-old boy who killed himself while taking the antidepressant.

  • September 4, 2008

    3rd Circ. Reverses WARN Act Exemption Ruling

    Defunct trucking company APA Transport Corp. will have to come up with a new defense for its failure to provide hundreds of employees with a 60-day notice of termination, now that an appeals court has reversed a lower court's decision to throw out the case by allowing the company to hide behind the “faltering company” exception to the Worker Adjustment and Retraining Notification Act.

  • September 4, 2008

    WolfBlock, Akerman Abandon Plans To Merge

    Citing client conflicts and an economic downturn, WolfBlock LLP and Akerman Senterfitt have ended talks of a potential merger.

  • September 4, 2008

    New Priority Superfund Sites Named, More Proposed

    The U.S. Environmental Protection Agency has named six new Superfund sites to its National Priorities List and proposed adding an additional 10 sites, elevating them to high-priority areas in need of investigations into the potential health and environmental risks they pose.

  • September 4, 2008

    Apotex Loses Appeal In Risperdal Patent Fight

    A federal appeals court on Thursday upheld a district judge's decision to dismiss Apotex Inc.'s counterclaims of noninfringement in connection with a patent fight over Johnson & Johnson subsidiary Janssen's anti-psychotic drug Risperdal.

  • September 3, 2008

    Court Rejects Knee Implant Patent Claim Construction

    A federal appeals court has dealt Howmedica Osteonics Corp. a win in a long-running patent dispute between rival orthopedic implant makers over knee implants, vacating a stipulated judgment of noninfringement because of flaws in the lower court's claim construction.

  • September 4, 2008

    Healthfirst To Pay $35M Over Medicaid Fraud

    Healthfirst, the largest Medicaid managed-care provider in New York state, has agreed to pay $35 million to settle an investigation into its prior marketing practices.

  • September 3, 2008

    Amended ANDA Triggers Another Detrol Complaint

    Pfizer Inc. has filed a new suit against Impax Laboratories Inc. over Impax's attempts to move into the lucrative market for Detrol LA, after Impax changed an abbreviated new drug application to cover a different dosage strength.

  • September 3, 2008

    Teva Sues Glenmark In Latest Suit Over Generic Coreg

    Teva Pharmaceuticals Industries Ltd. has filed a lawsuit accusing rival generic-drug maker Glenmark Pharmaceuticals Ltd. of infringing patents for the preparation of a generic version of Coreg, GlaxoSmithKline PLC's congestive heart failure treatment.

  • September 2, 2008

    Ohio Lead Paint Suit Belongs In State Court: Judge

    A lawsuit by the state of Ohio accusing lead paint manufacturers and distributors of creating a public nuisance in the state has no business in federal court, a magistrate judge has ruled, recommending that the matter be remanded to state court where it was originally filed.

  • September 2, 2008

    Pa. Funeral Directors Admit Body Part Theft

    Two Philadelphia brothers who operated a funeral home pled guilty Tuesday to several charges in connection with a multimillion-dollar human tissue harvesting ring, their lawyers have confirmed.

  • September 2, 2008

    Linens 'N Things Files Ch. 11 Reorganization Plan

    Less than four months after seeking Chapter 11 protection, home products retailer Linens 'N Things has filed a joint plan of reorganization that calls for closing nearly 200 stores and grants its creditors ownership of the company.

  • September 2, 2008

    Some Antitrust Allegations Against Avaya Upheld

    A judge has allowed counterclaims of monopolization, attempted monopolization and illegal conspiracy against leading phone maintenance company Avaya Inc. but dismissed some other counterclaims by a competing maintenance firm.

  • August 29, 2008

    Judge Stays Generics Companies' Nexium Cases

    A judge on Thursday stayed two noninfringement lawsuits brought by generic-drug makers against AstraZeneca Corp. pending the outcome of AstraZeneca's earlier Nexium-related infringement cases.

  • August 29, 2008

    Sanofi-Aventis Sues Apotex Over ANDA For Eloxatin

    Sanofi-Aventis has targeted Canada's Apotex Corp. in its latest effort to keep a generic version of colon cancer drug Eloxatin off the market in the United States.

  • August 28, 2008

    Judge Issues Mixed Ruling In Conexant ERISA Suit

    A federal judge on Wednesday upheld key allegations in a putative class action after an employee of semiconductor-maker Conexant Systems Inc. accused it of mismanaging its 401(k) plan by overloading it with company stock, potentially costing employee-investors millions.

  • August 28, 2008

    Breckenridge Must Stop Selling Multivitamin: Judge

    A federal judge handed Everett Laboratories Inc. a victory Tuesday in its patent infringement case by ordering Breckenridge Pharmaceutical Inc. to stop selling and marketing multivitamin Multifol Plus in the United States.